Skip to content

Author

M. Inglese

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

A two-year single-site longitudinal assessment of brain and retinal atrophy in ocrelizumab-treated relapsing–remitting multiple sclerosis

Ocrelizumab is an effective treatment for relapsing–remitting multiple sclerosis (RRMS), but its impact on brain and retinal atrophy requires further investigation. To assess the effects of ocrelizumab on brain and retinal atrophy over two years and explore the relationship between imaging biomarkers, early inflammat...

M. Cellerino, C. Lapucci, S. Magon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.